Company Encyclopedia
View More
name
Kingmed Diagnostics
603882.SH
Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides health check-up, cold chain logistics, and other services. Guangzhou Kingmed Diagnostics Group Co., Ltd.
82.57 B
603882.SHMarket value -Rank by Market Cap -/-

Financial Score

07/12/2025 Update
D
Health Care ServicesIndustry
Industry Ranking6/8
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-7.57%D
    • Profit Margin-9.08%D
    • Gross Margin36.55%C
  • Growth ScoreE
    • Revenue YoY-22.17%E
    • Net Profit YoY-444.09%E
    • Total Assets YoY-11.52%E
    • Net Assets YoY-13.22%E
  • Cash ScoreE
    • Cash Flow Margin-1101.31%E
    • OCF YoY-22.17%E
  • Operating ScoreB
    • Turnover0.59B
  • Debt ScoreB
    • Gearing Ratio28.41%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Kingmed Diagnostics: Third quarter net profit of 5.1973 million yuan, a year-on-year increase of 24.08%

    Kingmed Diagnostics announced that its revenue for the third quarter was 1.541 billion yuan, a year-on-year decrease of 11.32%; net profit was 5.1973 million yuan, a year-on-year increase of 24.08%. Revenue for the first three quarters was 4.538 billion yuan, a year-on-year decrease of 19.23%; net profit recorded a loss of 79.6095 million yuan, a year-on-year decrease of 184.84%

    Zhitong·
    SH
    603882
    -0.21%
    Zhitong·
    SH
    603882
    -0.21%

    The cancer pathology gene large model DeepGEM is implemented

    On October 23rd, a reporter learned from Kingmed Diagnostics that the cancer pathology gene large model DeepGEM has recently been deployed at the company. Relying on this large model, the company will collaborate with Tencent and the First Affiliated Hospital of Guangzhou Medical University to jointly develop a multimodal large model for pathological genes, allowing accurate, timely, and accessible gene mutation prediction technologies to benefit more cancer patients. (Science and Technology Daily)

    Wallstreetcn·
    SH
    603882
    -0.21%
    Wallstreetcn·
    SH
    603882
    -0.21%

    Kingmed Diagnostics: Has launched testing for Chikungunya virus

    Kingmed Diagnostics stated on the interactive platform that the company, relying on its comprehensive platforms and technologies such as serology, fluorescence PCR, and first and second generation sequencing at the infection testing center, has launched testing for chikungunya virus, which can accurately identify pathogens and assist in precise clinical diagnosis

    Zhitong·
    SH
    603882
    -0.21%
    Zhitong·
    SH
    603882
    -0.21%

    Kingmed Diagnostics: Expected net profit loss of RMB 65 million to RMB 95 million in the first half of 2025

    Kingmed Diagnostics announced that it expects to achieve a net profit attributable to shareholders of the listed company of -65 million yuan to -95 million yuan for the first half of 2025, a year-on-year turnaround from profit to loss. It is expected that the net profit attributable to shareholders of the listed company, after deducting non-recurring gains and losses, will be -78 million yuan to -110 million yuan for the first half of 2025

    Zhitong·
    SH
    603882
    -0.21%
    Zhitong·
    SH
    603882
    -0.21%

    Kingmed Diagnostics shareholder Guochuang Kaiyuan plans to reduce its holdings by no more than 1%

    According to the Zhitong Finance APP, Kingmed Diagnostics announced that its shareholder Guochuang Kaiyuan intends to reduce its holdings of the company's shares by no more than 4.6326 million shares through centralized bidding, accounting for 1.00% of the company's total share capital

    Zhitong·
    SH
    603882
    -0.21%
    Zhitong·
    SH
    603882
    -0.21%
    © 2025 Longbridge｜Disclaimer